{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:04:41Z","timestamp":1773299081666,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1896,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidem. Drug Safe."],"DOI":"10.1002\/pds.1964","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T10:34:28Z","timestamp":1277289268000},"page":"808-813","source":"Crossref","is-referenced-by-count":22,"title":["Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study"],"prefix":"10.1002","volume":"19","author":[{"given":"Marian K.","family":"Bakker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermien E. K.","family":"De Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lolkje T. W. de Jong-Van Den","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,23]]},"reference":[{"key":"10.1002\/pds.1964-BIB1|cit1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JRS-1994-6201","article-title":"Malformation surveillance and maternal drug exposure: the MADRE project","volume":"6","author":"Robert","year":"1994","journal-title":"Int J Risk Saf Med"},{"issue":"26","key":"10.1002\/pds.1964-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1056\/NEJMsb031395","article-title":"Systematic identification of drugs that cause birth defects-a new opportunity","volume":"349","author":"Mitchell","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1002\/pds.1964-BIB3|cit3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00002018-200730040-00003","article-title":"Postmarketing analysis of medicines: methodology and value of the spanish case-control study and surveillance system in preventing birth defects","volume":"30","author":"Martinez-Frias","year":"2007","journal-title":"Drug Saf"},{"issue":"3","key":"10.1002\/pds.1964-BIB4|cit4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/pds.571","article-title":"Signal generation and clarification: use of case-control data","volume":"10","author":"Kaufman","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.1964-BIB5|cit5","unstructured":"http:\/\/www.whocc.no\/atc_ddd_index\/ [Accessed on 2 December 2004]"},{"issue":"2-3","key":"10.1002\/pds.1964-BIB6|cit6","first-page":"97","article-title":"Birth defect and risk factor surveillance in the northern and southwestern Netherlands","volume":"2","author":"Reefhuis","year":"1999","journal-title":"Community Genet"},{"issue":"9","key":"10.1002\/pds.1964-BIB7|cit7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/bdra.20388","article-title":"Selection of controls in case-control studies on maternal medication use and risk of birth defects","volume":"79","author":"Bakker","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"5","key":"10.1002\/pds.1964-BIB8|cit8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","article-title":"Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study","volume":"66","author":"Diav-Citrin","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1002\/pds.1964-BIB9|cit9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1002\/pds.1964-BIB10|cit10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/00002018-200528070-00002","article-title":"Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant","volume":"28","author":"Nordeng","year":"2005","journal-title":"Drug Saf"},{"key":"10.1002\/pds.1964-BIB11|cit11","unstructured":"Eurocat Northern Netherlands http:\/\/www.rug.nl\/umcg\/faculteit\/disciplinegroepen\/MedischeGenetica\/Eurocat\/professionals\/tabellen [Accessed on 29 May 2009]"},{"issue":"2","key":"10.1002\/pds.1964-BIB12|cit12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.ede.0000192032.83843.c9","article-title":"The continuing enigma of pyloric stenosis of infancy: a review","volume":"17","author":"MacMahon","year":"2006","journal-title":"Epidemiology"},{"issue":"7","key":"10.1002\/pds.1964-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1523\/JNEUROSCI.16-07-02352.1996","article-title":"Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract","volume":"16","author":"Wade","year":"1996","journal-title":"J Neurosci"},{"issue":"1","key":"10.1002\/pds.1964-BIB14|cit14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/pds.1964-BIB15|cit15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0736-5748(01)00022-3","article-title":"Developmentally regulated serotonin 5-HT2B receptors","volume":"19","author":"Nebigil","year":"2001","journal-title":"Int J Dev Neurosci"},{"issue":"3","key":"10.1002\/pds.1964-BIB16|cit16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02246453","article-title":"Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor","volume":"126","author":"Palvimaki","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1002\/pds.1964-BIB17|cit17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7150\/ijms.3.106","article-title":"No increased risk of infant hypospadias after maternal use of loratadine in early pregnancy","volume":"3","author":"Kallen","year":"2006","journal-title":"Int J Med Sci"},{"issue":"26","key":"10.1002\/pds.1964-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1964","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.1964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T19:42:32Z","timestamp":1711568552000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,23]]},"references-count":18,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1002\/pds.1964","relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,23]]}}}